An error has occurred, the report has not been sent. Please check if the data is valid or try again later.
Report a problem related to object: Economic Evaluation of Crohn’s Disease Treatment with Vedolizumab and Ustekinumab After Failure of Tumour Necrosis Factor-alpha Antagonist